Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2021-02-20
2021-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes
NCT04550403
The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19
NCT04591704
The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19
NCT04663659
"COVID-19 and Diabetes Outcomes"
NCT04324736
Glycaemia and Cardiac Function in Patients With COVID-19
NCT04410718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
COVID-19 infected patients with no other comorbidities and they take the routine protocol from the Egyptian ministry of health
no intervention as it is an observational study
both groups will be monitored for the disease progress or deterioration and mortality rate
diabetic group
COVID-19 infected patients with diabetes comorbidity and they receive the routine protocol for covid treatment in addition to their hypoglycemic drugs
no intervention as it is an observational study
both groups will be monitored for the disease progress or deterioration and mortality rate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention as it is an observational study
both groups will be monitored for the disease progress or deterioration and mortality rate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia K. Zaafar
lecturer of pharmacology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University teaching hospitals
Cairo, Kasr Al Ainy, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ITH00131
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.